Country antimalarial drug policies: by region
- WHO African Region
- WHO Region of the Americas
- WHO South-East Asia Region
- WHO European Region
- WHO Western Pacific Region
WHO Eastern Mediterranean Region
| Global AMDP database - WHO Eastern Mediterranean region | |||||||||
| Last Updated: December 2012 | P. falciparum | P.vivax | |||||||
| COUNTRY/ AREA | SPECIES | uncomplicated | treatment failure | severe malaria | pregnancy | treatment | |||
| un- confirmed | lab- confirmed | treatment | prevention | ||||||
| Afghanistan | P.f, P.v | - | CQ | AS+SP | QN | - | AS+SP - 2nd; 3rd trimester; QN | CQ+PQ(14d) | |
| Djibouti | P.f, P.v | - | AS+SP | AS+SP | AL | - | AS+SP - 2nd; 3rd trimester; QN | CQ+PQ(14d) | |
| Iran (Islamic Republic of) | P.f, P.v | - | - | AS+SP | AL | - | - | CQ+PQ(14d) | |
| Pakistan | P.f, P.v | - | CQ | AS+SP | QN | - | CQ | CQ+PQ(14d) | |
| Saudi Arabia | P.f, P.v | - | - | AS+SP | AL | - | - | CQ+PQ(14d) | |
| Somalia | P.f, P.v | - | AS+SP | AS+SP | QN | SP(IPT) | QN | CQ+PQ(14d) | |
| South Sudan | P.f, P.v | - | AS+AQ | AS+AQ | AL | SP(IPT) | AS+AQ; QN | AS+AQ+PQ | |
| Sudan | P.f, P.v | - | AS+SP | AS+SP | AL | SP(IPT) | AS+SP ( 2nd option from 13 wks); QN | AL | |
| Yemen | P.f, P.v | - | AS+SP | AS+SP | AL | - | - | CQ+PQ(14d) | |
AL=Artemether-lumefantrine
D=Doxycycline
PYR=Pyronaridine
AM=Artemether
DHA=Dihydroartemisinin
QN=Quinine
AQ=Amodiaquine
MQ=Mefloquine
SP=Sulphadoxine-pyrimethamine
ART=Artemisinin
NQ=Naphroquine
T=Tetracycline
AS=Artesunate
PG=Proguanil
CL=Clindamycline
PPQ=Piperaquine
CQ=Chloroquine
PQ=Primaquine